Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermatix Q for Scar Prevention and Management
NCT00450775Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2007
- Primary completion
- Mar 2008
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of kelocote in Hypertrophic Scar (HS), sponsored by Janssen Pharmaceutical. Started Mar 2007; status: completed.
02
Drugs
kelocote
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT00450775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450775.